<DOC>
	<DOCNO>NCT01121081</DOCNO>
	<brief_summary>This Randomized , Double-Blind , , Placebo Controlled , 18 Week Study To Evaluate Efficacy adjuvant 9-cis-β-Carotene Rich powder Alga Dunaliella bardawil Subjects With Plaque type Psoriasis treat Narrow Band UVB therapy .</brief_summary>
	<brief_title>The Effect Algae Dunaliella Bardawil Psoriasis ( 2 )</brief_title>
	<detailed_description>This double blind , parallel group , randomize study 12 week daily oral administration Dunaliella placebo psoriasis patient undergoing phototherapy . Subjects screen eligibility baseline visit phototherapy blood test . After screen phase maximum two week subject randomized phototherapy treatment . 4 one two treatment group ( 2:1 ) : Dunaliella placebo . Each subject final evaluation 4 week end study drug treatment .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Subjects meet ALL follow criterion consider enrollment study : 1 . Signed dated write Institutional Review Board ( IRB ) Independent Ethics Committee ( IEC ) approve informed consent obtain subject accordance local regulation ; 2 . Male female subject , ≥18 ≤75 year age , diagnosis plaque guttate psoriasis ; 3 . Psoriasis Area Severity Index ( PASI ) score ≥12 psoriasis cover ≥10 % body surface area ( BSA ) 4 . Psoriasis severity least moderate , score least 3 0 5 point Physician Global Assessment ( PGA ) scale National Psoriasis Foundation Psoriasis Score ( NPFPS ) 5 . Candidate phototherapy treatment start visit 0 . 6 . For female subject ; either : subject nonchildbearing potential , define : menopause amenorrhea &gt; 2 year , hysterectomy , bilateral oophorectomy agrees continue use adequate contraception ( i.e. , hormonal [ oral , depot , patch ] , IUD , barrier spermicide ) throughout study least one month follow termination negative urinary pregnancy test screen first dose study drug ; 7 . In opinion investigator , subject compliant high probability complete study require procedure . Subjects meet ANY follow criterion exclude participation study : 1 . The subject present predominant type psoriasis erythrodermic , inverse , pustular pulmoplantar unstable form psoriasis ; 2 . Received investigational drug within 30 day randomization . 3 . The subject undergone washout period sufficient duration follow treatment Baseline : Topical psoriasis treatment : 2 week Systemic psoriasis treatment : 4 week 5 half life ( whichever longer ) Phototherapy climatotherapy : 4 week Biologic treatment : 4 week 4 . The subject anticipate get enough extra trial ultraviolet light study ( e.g . sunbathe ; tan salon , etc . ) cause psoriasis improve ; 5 . The subject know allergy sensitivity study treatment ( ) participant contain study drug formulation 6 . Any acute chronic medical condition , opinion investigator , increase risk subject likelihood subject unable complete study ; 7 . Subjects laboratory test screening consider significantly abnormal . The following consider significantly abnormal : Alanine transaminase ( ALT ) , aspartate transaminase ( AST ) &gt; 3 upper limit normal . CPK &gt; 3 upper limit normal . Triglycerides &gt; 350mg/dl . cytopenia ( include follow : WBC &lt; 3.5x10 3/μL ; Hgb &lt; 10 g/dL ; platelet &lt; 120x10 3/μL ; neutrophil absolute &lt; 1.5x10 3/μL ; lymphocyte absolute &lt; 0.8x10 3/μL ) 8 . Personal first degree relative history malignant melanoma . 9 . Known serologic positivity human immunodeficiency virus hepatitis B C virus . 10 . History substance abuse , include alcohol abuse , within past year . 11 . History current clinically significant major psychiatric disorder ( e.g. , major depressive disorder , psychosis , schizophrenia ) accord criterion Diagnostic Statistical Manual Mental Disorders , Fourth Edition ( DSM IV TR ) [ Exception ; subject depression adequately control least 6 month may enroll study ] ; 12 . Female subject positive pregnancy test nursing , plan pregnancy course study ; 13 . Unwilling unable comply study requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Male female subject</keyword>
	<keyword>≥18 ≤75 year age</keyword>
	<keyword>diagnosis plaque guttate psoriasis</keyword>
</DOC>